US$ 20.57
does noom offer glp-1 offers cut-price compounded drug for obesity Noom’s New Microdose GLP-1 Program
Description
Learn how they work, how they differ, whether they can be combined, and what side effects to watch for.

Background/objectives: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in treating type 2 diabetes and obesity, offering established metabolic and cardiovascular benefits

Fair editorial context for readers

GLP-1 is a natural hormone your body produces after meals
Evidence-based UK guidance for patients.
